Submit

Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Fund House: Tata Mutual Fund
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 28-12-2015
Asset Class: Equity
Benchmark: Nifty Pharma TRI
Expense Ratio: 2.5% As on (31-12-2022)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 515.73 Cr As on (31-12-2022)
Turn over: 29.52% | Exit Load: 0.25% for redemption within 30 days
NAV as on 01-02-2023

16.2191

-0.06 (-0.3761%)

CAGR Since Inception

7.0%

NIFTY 50 TRI 13.06%

PERFORMANCE

Returns Type:
of  : 
Start :  
End : 
Period:  
This Scheme
-
vs
NIFTY 50 TRI
-
Gold
-
PPF
-
Returns Type:
of  : 
  Period:  

Start :  
Period:  

RETURNS ANALYSIS

Submit
Submit
Submit

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

Time Taken To Multiply
2x
4x
5x
10x
FUND
There is no value for 2x
There is no value for 4x
There is no value for 5x
There is no value for 10x
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months

 

Investment Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Current Asset Allocation (%)

Indicators

Standard Deviation 19.12
Sharpe Ratio 0.93
Alpha 3.19
Beta 0.84
Yield to Maturity -
Average Maturity -

PEER COMPARISON

Scheme Name Inception
Date		 1 Year
Return(%)		 2 Year
Return(%)		 3 Year
Return(%)		 5 Year
Return(%)		 10 Year
Return(%)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 -5.34 5.75 19.04 12.81 -
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 -1.73 6.31 20.59 11.33 13.78
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 -3.34 7.04 22.33 - -
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 -5.68 6.01 20.66 14.02 15.13
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 -6.11 - - - -
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 -6.95 4.87 20.09 - -
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 -8.81 7.4 21.83 - -
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 -9.41 3.06 18.02 10.23 11.94
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 -9.58 1.15 14.3 - -
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 -9.62 2.82 14.13 - -

Scheme Characteristics

Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.

Riskometer

riskometer

PORTFOLIO

Market Cap Distribution

Small Cap

18.53%

Others

1.78%

Large Cap

49.24%

Mid Cap

30.44%

Scheme Documents

There are no scheme documents available

Tax Benefits of investing in this fund

Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#

Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.

Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **

# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund

Feedback
Notification